PRLAX
Price
$24.19
Change
-$0.12 (-0.49%)
Updated
Jul 24 closing price
Net Assets
456.79M
VPACX
Price
$20.67
Change
-$0.32 (-1.52%)
Updated
Jul 24 closing price
Net Assets
13.83B
Interact to see
Advertisement

PRLAX vs VPACX

PRLAX vs VPACX Comparison Chart in %
View a ticker or compare two or three
VS
PRLAX vs. VPACX commentary
Jul 27, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRLAX is a Hold and VPACX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VPACX has more cash in the bank: 13.8B vs. PRLAX (457M). PRLAX pays higher dividends than VPACX: PRLAX (2.92) vs VPACX (2.55). PRLAX was incepted earlier than VPACX: PRLAX (33 years) vs VPACX (36 years). PRLAX (1.51) is less costly to investors than VPACX (0.23). PRLAX is a more actively managed with annual turnover of: 34.20 vs. VPACX (7.00). VPACX has a lower initial minimum investment than PRLAX: VPACX (0) vs PRLAX (2500). VPACX annual gain was more profitable for investors over the last year : 29.68 vs. PRLAX (24.88). VPACX return over 5 years is better than : 36.19 vs. PRLAX (22.35).
PRLAXVPACXPRLAX / VPACX
Total Expense Ratio1.470.23639%
Annual Report Gross Expense Ratio1.510.23657%
Fund Existence33 years36 years-
Gain YTD9.40819.61848%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets457M13.8B3%
Annual Yield % from dividends2.922.55114%
Returns for 1 year24.8829.6884%
Returns for 3 years21.1854.7139%
Returns for 5 years22.3536.1962%
Returns for 10 years46.5898.5047%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RPRX58.83-0.19
-0.32%
Royalty Pharma plc
CANF3.19-0.04
-1.24%
Can-Fite Biopharma Ltd
AURA7.05-0.15
-2.08%
Aura Biosciences
CLMT41.69-1.13
-2.64%
Calumet Inc.
DLNG3.61-0.24
-6.23%
Dynagas LNG Parners LP